PharmaNordic ApS: Financial statements 2017
CVR: 36408464
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 242,124 and a net result of DKK -51,053 compared with DKK -64,864 the year before. That is an increase of 27.5% compared with the year before. Equity in the 2017 report amounted to DKK -250,549.
- Gross Profit
- DKK 242,124
- Profit/Loss
- DKK -51,053
- Equity
- DKK -250,549
- Total Assets
- DKK 183,469
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 242 t. | -51 t. | -251 t. | - |
| 2016 | - | 190 t. | -65 t. | -199 t. | - |
Keep an eye on PharmaNordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PharmaNordic ApS has published its annual report for 2016. Gross profit came to DKK 189,947, and the net result was DKK -64,864.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.